Roth Capital Maintains Neutral Rating on $FTNT Amid Analyst Insights

Recent analyst forecasts indicate a ‘Neutral’ rating for $FTNT from Roth Capital.

Analyst Ratings Overview for $FTNT

In the past few months, Wall Street analysts have actively reviewed $FTNT. Notably, four firms have issued buy ratings while none have given sell ratings.

You can view recent analyst opinions here:

• Goldman Sachs rated it “Buy” on 01/02/2025
• KeyBanc rated it “Overweight” on 12/19/2024
• Morgan Stanley rated it “Overweight” on 12/02/2024
• Cowen & Co. rated it “Buy” on 11/19/2024

For ongoing tracking of analyst ratings and price targets for $FTNT, please see Quiver Quantitative’s forecast page.

Price Targets Set for $FTNT

Seven analysts have released price targets for $FTNT over the last six months, resulting in a median target of $103.0.

Current price targets from analysts can be found here:

• UBS set a target price of $123.0 on 03/18/2025
• Eric Heath from KeyBanc set a target price of $115.0 on 12/19/2024
• Adam Borg from Stifel Nicolaus set a target price of $103.0 on 12/18/2024
• Catherine Trebnick from Rosenblatt Securities targeted $100.0 on 11/19/2024
• Stephen Bersey from HSBC set a target price of $111.0 on 11/11/2024
• Keith Bachman from BMO Capital set a target price of $88.0 on 11/08/2024
• Saket Kalia from Barclays set a target price of $85.0 on 11/04/2024

Congressional Trading of $FTNT Stock

Within the past six months, members of Congress have engaged in trades involving $FTNT stocks three times, comprising two purchases and one sale.

For more details on these recent trades, click here.

For tracking congressional stock trading activity, see Quiver Quantitative’s dashboard on congressional transactions.

Insider Trading Activity at $FTNT

In the last six months, $FTNT insiders have executed 57 trades in the open market, with just two purchases and 55 sales.

Details of the recent insider trading activity can be found here:

• KEN XIE (PRESIDENT & CEO): 0 purchases, 30 sales, 389,156 shares sold for about $38,093,536.
• MICHAEL XIE (VP, ENGINEERING & CTO): 0 purchases, 7 sales, 351,496 shares sold for roughly $34,028,399.
• KEITH JENSEN (CFO): 0 purchases, 14 sales, 119,765 shares sold for about $11,511,466.
• JOHN WHITTLE (COO): 0 purchases, 2 sales, 38,495 shares sold for approximately $3,293,666.
• KENNETH A GOLDMAN: 0 purchases, 2 sales, 3,000 shares sold for approximately $299,320.
• WILLIAM H. NEUKOM: 2 purchases, 683 shares bought for around $69,845.

To monitor insider trading further, see Quiver Quantitative’s dashboard.

Hedge Fund Activity Involving $FTNT

In the most recent quarter, 602 institutional investors increased their holdings of $FTNT, while 514 reduced their positions.

Highlighted recent transactions include:

• NORGES BANK added 6,759,922 shares (+748.1%), totaling about $638,677,430.
• FMR LLC added 2,846,475 shares (+77.2%), amounting to about $268,934,958.
• ARROWSTREET CAPITAL added 2,151,811 shares (+39.3%), equating to around $203,303,103.
• BESSEMER GROUP INC added 2,064,016 shares (+72.6%), with an estimated total of $195,008,231.
• SWEDBANK AB withdrew 2,015,745 shares (-29.6%), valued at approximately $190,447,587.
• INVESCO LTD. added 2,000,888 shares (+31.3%), totaling around $189,043,898.
• MILLENNIUM MANAGEMENT LLC reduced their holdings by 1,811,984 shares (-49.9%), valued at about $171,196,248.

For insights into hedge fund portfolios, visit Quiver Quantitative’s institutional holdings dashboard.

This article is not financial advice. Please review Quiver Quantitative’s disclaimers for more information.

This article originally appeared in Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.